Skip to main content

Education First

Site section 6 of 12

Blood types are antigen, antibody, and compatibility systems.

A professional transfusion-literacy course on ABO/RhD, ISBT systems, antigens, antibodies, testing workflows, component rules, rare blood, pregnancy and neonatal context, chronic transfusion, transplant, and emergency-boundary logic.

Learning progress

Progress is private to this browser.

Core instrument

Antigen and antibody grammar.

The first live interaction makes the shortcut visible: a label is produced from surface antigens, but the real workflow also needs method, component, history, and scenario context.

Antigen antibody builder

Toggle the surface antigens and read the summary label and the antibodies the plasma is expected to hold.

Modeled
Surface antigens
Red cell surface, schematicA on HH only, no BRhD protein

Summary label

A, RhD-positive label

Expected antibody pattern

expected anti-B

Group A: the plasma holds what the cells lack.

expected anti-B. A and B antibodies arise without exposure, against the ABO antigens the cells do not carry. RhD is present, so anti-D does not arise. The label summarizes the surface; component, history, antibody screen and crossmatch decide the laboratory workflow.

Summary label A, RhD-positive label. Expected antibody pattern: expected anti-B.

Method and sources

A, B built on H; plasma anti-A, anti-B against the ABO antigens absent; no H: anti-A, anti-B, anti-H

What it shows: A schematic red-cell surface with the H, A, B and RhD antigens, and the ABO/H antibodies the plasma is expected to hold for that surface.

How to read it: Each toggle adds or removes one antigen. A and B are sugars added to the H antigen, so with H absent they draw as empty outlines and the label reads the Oh (Bombay) pattern.

Assumptions: Expected antibodies follow Landsteiner’s rule for ABO; anti-D is immune and appears only after exposure. Subgroups, secretor status and unexpected antibodies are outside the model.

Sources:
  • NCBI Bookshelf, Blood Groups and Red Cell Antigens Background on red cell antigens, ABO, Rh, and non-ABO systems.
  • International Society of Blood Transfusion, ISBT Red Cell Immunogenetics and Blood Group Terminology Official blood group system and terminology governance.
  • AABB, Standards for Blood Banks and Transfusion Services, 35th edition Current transfusion-service standards context.
The output is a synthetic teaching state and never a component recommendation.

Check yourself

Classify the first safe move.

A learner sees an ABO/Rh label and wants to treat it as a complete compatibility answer. The course has to force the missing evidence back into view.

Choose the next move

Pick an answer to see why.

Professional course contract

The eight common labels are the doorway, not the course.

Every idea here is an antigen, an antibody, an allele or phenotype, a method, a component, a scenario, or a limitation. The course builds from ABO/RhD into non-ABO systems, crossmatch logic, discrepancy handling, and high-stakes boundaries.

Lessons
18
Covers
Systems, antigens, antibodies, tests, and scenarios
Status
Source-reviewed education

Testing

Agglutination and crossmatch are workflows.

The course teaches where observations come from, why discrepancies happen, and when a case leaves the beginner chart.

Agglutination simulator

Set the synthetic cells and plasma, and read the forward and reverse wells, each graded 0 to 4+, and whether the two typings agree.

Modeled
Synthetic case
Cell antigens
A or B expression
RhD
Plasma anti-A and anti-B
0%

Forward type

A

RhD positive

Reverse type

A

Concordance

concordant

Forward and reverse agree: A.

The cells carry the antigens of group A and the plasma holds the antibodies that group is expected to carry, all at full strength. Agreement is the precondition for recording a type, not a compatibility decision.

Forward A, RhD positive; reverse A; concordant. Wells: anti-A 4+, anti-B 0, anti-D 3+, control 0, A1 cells 0, B cells 3+.

Method and sources

forward: anti-A, anti-B on the cells; reverse: A1, B cells in the plasma; concordant when both give one group at full strength

What it shows: A synthetic tube typing. Antisera find the antigens on the cells (forward); reagent A1 and B cells find the antibodies in the plasma (reverse). Each well is graded on the 0 to 4+ scale.

How to read it: A present antigen reacts 4+ (1+ for a weak subgroup); anti-D reacts 3+ (1+ for weak D). Expected plasma antibodies react 3+ (1+ when weak). A second population of group O RhD negative cells reacts with nothing, so a forward well reacts in only part of the cells: a mixed field.

Acceptance and scale: Discrepant when the forward and reverse groups differ; resolve first when they agree but a reaction is weak, a mixed field shows, or anti-D is weak; concordant only otherwise.

Assumptions: Forward ABO below 3+ and reverse below 2+ count as weaker than expected. Cold autoantibodies, rouleaux and unexpected antibodies are outside the model, and the control well stays clean.

Sources:
  • AABB, Standards for Blood Banks and Transfusion Services, 35th edition Current transfusion-service standards context.
  • NCBI Bookshelf, Blood Groups and Red Cell Antigens Background on red cell antigens, ABO, Rh, and non-ABO systems.
  • Canadian Blood Services Professional Education, Pre-transfusion testing Testing sequence, type and screen, antibody screen, and crossmatch concepts.
The wells are a computed teaching model, not a reading of any sample, and never a compatibility or transfusion decision.

Testing and crossmatch flow

The course teaches how observations are produced before it teaches what they can organize. Each method has a specimen, reagent context, output, limitation, and escalation path.

Testing method

Forward ABO typing

Specimen or input
Patient red cells plus anti-A and anti-B reagents.
Method
Agglutination-based detection of A and B antigens.
Output
Pattern of red-cell agglutination.
Escalation
Investigate ABO discrepancy before final interpretation.

Components

One compatibility chart cannot do this job.

Red cells, plasma, platelets, cryoprecipitate, whole blood, transplant, and emergency release all carry different questions.

Component compatibility explorer

Select the component first. The course refuses to reuse one chart for red cells, plasma, platelets, cryoprecipitate, whole blood, transplant, and emergency contexts.

Component rule

Red cells: ABO

Red-cell ABO compatibility is antigen-on-donor-cell versus antibody-in-recipient-plasma logic.

Recipient issue
Recipient plasma antibodies can react with donor red-cell ABO antigens.
Donor issue
Donor red-cell A, B, and H-related antigen expression matters.
Cannot decide here
  • Personal unit selection
  • Emergency choice
  • Need for transfusion
Emergency caveat
Emergency release is a controlled clinical workflow, not public instruction.

System atlas

ABO/RhD is the entry layer.

The atlas exposes ISBT system scale and shows why Kell, Duffy, Kidd, MNS, Diego, Lewis, P1PK, GLOB, Lutheran, Dombrock, Colton, Yt, Xg, Scianna, Cromer, Knops, Vel, Lan, CD36, MAL, and PIGZ exist in the course contract.

ISBT 001

ABO

ABO

A, B, AB, and O patterns depend on A/B transferase activity layered on H substance.

Genes: ABO

Antigens: A, B, A1

ISBT 018

H

H

H antigen is the substrate for A and B antigen expression on red cells.

Genes: FUT1

Antigens: H

ISBT 004

Rh

RH

D, C, c, E, and e are inherited through RHD/RHCE variation and can include weak or partial expression.

Genes: RHD, RHCE

Antigens: D, C, c, E, e

ISBT 006

Kell

KEL

K and k are core teaching antigens; K is important in transfusion and pregnancy literacy.

Genes: KEL

Antigens: K, k, Kpa, Kpb, Jsa, Jsb

ISBT 008

Duffy

FY

Fya and Fyb expression varies by allele and promoter context.

Genes: ACKR1

Antigens: Fya, Fyb

ISBT 009

Kidd

JK

Jka and Jkb are core antigens; Kidd antibodies can become hard to detect over time.

Genes: SLC14A1

Antigens: Jka, Jkb

ISBT 002

MNS

MNS

M, N, S, s, and U are the central teaching antigens.

Genes: GYPA, GYPB

Antigens: M, N, S, s, U

ISBT 010

Diego

DI

Dia and Dib are central Diego teaching antigens.

Genes: SLC4A1

Antigens: Dia, Dib

ISBT 007

Lewis

LE

Lea and Leb expression depends on Lewis and secretor biology.

Genes: FUT3

Antigens: Lea, Leb

ISBT 003

P1PK

P1PK

P1 and related antigens connect to P-system literacy.

Genes: A4GALT

Antigens: P1

ISBT 028

GLOB

GLOB

P antigen context is distinguished from P1PK in the atlas.

Genes: B3GALNT1

Antigens: P

ISBT 005

Lutheran

LU

Lua and Lub are core Lutheran teaching antigens.

Genes: BCAM

Antigens: Lua, Lub

High-stakes contexts

Pregnancy, neonates, chronic support, rare blood, transplant, and emergency context stay bounded.

These modules explain what changes the laboratory question while refusing to provide personal or emergency instructions.

Capstone

Scenarios end with safe conclusions.

The workbench trains learners to separate known facts from missing context, then hand the real decision back to qualified teams.

Scenario workbench

Each capstone case ends with known facts, missing information, the highest-risk misunderstanding, and what this course cannot decide.

Scenario

ABO discrepancy

Forward and reverse ABO mismatch

Highest-risk failure: Treating a discrepancy as a normal ABO group before resolution.

Missing data
  • repeat specimen
  • reaction strength
  • history
  • control wells
Lab workflow
  • confirm identity
  • repeat forward and reverse grouping
  • review history
  • investigate weak, cold, rouleaux, mixed-field, or sample-error causes
Educational resolution
  • State known reactions
  • List missing context
  • Explain why final grouping is unresolved
Forbidden instruction
  • choose blood
  • ignore reverse group

Source record

Source record

The course cites its authorities.

Each medical, laboratory, and regulatory statement in this course traces to one of these authorities, with the date it was read.

ISBT Red Cell Immunogenetics and Blood Group Terminology

2026-07-02

International Society of Blood Transfusion / Official registry

Official blood group system and terminology governance.

ISBT Blood Group Database

2026-07-02

International Society of Blood Transfusion / Official registry

Blood group systems, antigens, genes, and allele records.

ISBT table of blood group systems

2026-07-02

International Society of Blood Transfusion / Official registry

Current source check for system scale and nomenclature.

Standards for Blood Banks and Transfusion Services, 35th edition

2026-07-02

AABB / Standard

Current transfusion-service standards context.

Circular of Information for the Use of Human Blood and Blood Components

2026-07-02

AABB, America’s Blood Centers, American Red Cross, and Armed Services Blood Program / Standard

Component, compatibility, and transfusion information boundary.

FDA guidance recognizing the June 2024 Circular of Information

2026-07-02

FDA / Regulation

Regulatory anchor for the recognized Circular of Information.

Blood Groups and Red Cell Antigens

2026-07-02

NCBI Bookshelf / Textbook

Background on red cell antigens, ABO, Rh, and non-ABO systems.

Pre-transfusion testing

2026-07-02

Canadian Blood Services Professional Education / Professional education

Testing sequence, type and screen, antibody screen, and crossmatch concepts.

Guidelines for pre-transfusion compatibility procedures

2026-07-02

British Society for Haematology / Guideline

Compatibility testing and discrepancy-resolution context.

Sickle Cell Disease Guidelines: Transfusion Support

2026-07-02

American Society of Hematology / Guideline

Chronic transfusion, extended antigen support, and SCD-specific context.

Prevention of Rh D Alloimmunization

2026-07-02

American College of Obstetricians and Gynecologists / Guideline

RhD alloimmunization and pregnancy education boundary.

Component compatibility

2026-07-02

Australian Red Cross Lifeblood / Professional education

Component-specific compatibility teaching anchor.

Blood types

2026-07-02

American Red Cross / Plain-language education

Plain-language ABO/RhD and rare blood framing.

OPTN policies

2026-07-02

Health Resources and Services Administration / Regulation

Transplant policy context for ABO-related concepts.

21 CFR 606 current good manufacturing practice for blood and blood components

2026-07-02

Electronic Code of Federal Regulations / Regulation

Blood and blood-component regulatory background.

42 CFR 493 laboratory requirements

2026-07-02

Electronic Code of Federal Regulations / Regulation

Clinical laboratory regulatory background.

Course boundary

A professional course knows what it cannot decide.

Back to courses

This course teaches language, systems, and laboratory workflow. It does not provide personal transfusion, pregnancy, donation, transplant, or emergency decisions.

Educational transfusion-literacy context only; not medical advice, transfusion instruction, emergency guidance, pregnancy management, donor eligibility advice, diagnosis, treatment guidance, dosing guidance, administration guidance, or evidence that any catalog item changes a biological outcome. The course uses synthetic educational cases only. Real transfusion, pregnancy, donation, transplant, and emergency decisions belong to qualified clinical and laboratory teams.

Editorial scope: chemical identity, experimental context, analytical methods, source quality and regulatory boundaries. Source references and stated limitations form part of the material; they should remain attached to quotations or summaries.

Lab and biomarker literacy path